The outcome of inflammatory and infectious diseases relies on the complex interaction among genetic factors, environmental triggers, dysregulated immune response, gut microbiota dysbiosis and features concerning the relationship between host and microorganisms. In the last decade, with the popularization of microbiome sequencing, the role of gut microbiota has been increasingly explored in health and disease, and its modulation by probiotics have demonstrated promising results and attracted considerable attention of the scientific and medical communities. Therefore, therapies direct or indirect modulating the gut microbial community may represent a promising approach to constrain the development of inflammatory disorders and progression of infectious diseases.
Despite the beneficial role of classical anti-inflammatory and anti-microbial drugs, patients may become intolerant, refractory or microbes may develop resistance to these therapeutic approaches. In addition, the modulation of gut microbiota by probiotics have shown promising results in the aforementioned conditions. Hence, this Research topic aims to publish original research and reviews on the role of Probiotics to prevent, treat or act as an adjuvant therapy to constrain inflammatory and infectious disorders.
The Topic Editors welcome original research and reviews on topics related but not limited to the following areas:
• Probiotics as therapeutic approaches to treat inflammatory or infectious diseases;
• Mechanisms of action of probiotics in the modulation on gut microbiota;
• Probiotic vectorization approaches towards intestinal targets
The outcome of inflammatory and infectious diseases relies on the complex interaction among genetic factors, environmental triggers, dysregulated immune response, gut microbiota dysbiosis and features concerning the relationship between host and microorganisms. In the last decade, with the popularization of microbiome sequencing, the role of gut microbiota has been increasingly explored in health and disease, and its modulation by probiotics have demonstrated promising results and attracted considerable attention of the scientific and medical communities. Therefore, therapies direct or indirect modulating the gut microbial community may represent a promising approach to constrain the development of inflammatory disorders and progression of infectious diseases.
Despite the beneficial role of classical anti-inflammatory and anti-microbial drugs, patients may become intolerant, refractory or microbes may develop resistance to these therapeutic approaches. In addition, the modulation of gut microbiota by probiotics have shown promising results in the aforementioned conditions. Hence, this Research topic aims to publish original research and reviews on the role of Probiotics to prevent, treat or act as an adjuvant therapy to constrain inflammatory and infectious disorders.
The Topic Editors welcome original research and reviews on topics related but not limited to the following areas:
• Probiotics as therapeutic approaches to treat inflammatory or infectious diseases;
• Mechanisms of action of probiotics in the modulation on gut microbiota;
• Probiotic vectorization approaches towards intestinal targets